Volume 16, Issue 3, March 2026, 101339Author links open overlay panelHuabei Wang, Zhimin Zhang, Guangyang Zhang, Ming Wen, Hongmei LuShow moreHighlights•

miRPVS enables ultra-fast virtual screening of small molecules targeting miRNA-protein complexes.

•

miRPVS achievs accurate docking score prediction compared to the traditional molecular docking method.

•

miRPVS enables tens of thousands of times acceleration compared to the traditional molecular docking method.

•

To our knowledge, this is the first study to use miRNA-protein complexes as targets for large-scale virtual screening.

Abstract

MicroRNAs (miRNAs) are small RNA molecules with significant therapeutic potential for treating various diseases, underscoring the need for effective methods to screen drugs targeting disease-associated miRNAs. In this study, we introduce miRPVS, a rapid virtual screening approach designed to identify small molecule drugs targeting miRNA-protein complex. miRPVS identifies binding pockets on the surface of these complexes, expanding the scope of potential small molecule targets. It employs an equivariant graph neural network model to extract three-dimensional (3D) structure features of small molecules, enabling accurate prediction of docking scores. Using miRPVS, four complexes involved in pri-miRNA cleaving, pre-miRNA transport, and mRNA depress were identified as promising targets. For each target, hit compounds were screened from the ZINC20 database, which contains approximately 600 million drug-like small molecules. MiRPVS predicted the docking score for these compounds, with Pearson correlation coefficients between predicted and experimentally docked scores comparable to those obtained through twice docking. Notably, the average deviation was only 0.67% across th4e four complexes. Remarkably, the entire screening process for all four complexes was completed in 14 h using just four V100 GPUs. Additionally, we integrated AlphaFold3-predicted structures into the miRPVS workflow, enabling virtual screening of small molecules against miRNA-protein complexes without experimentally determined structures. miRPVS demonstrated performance comparable to traditional docking methods while significantly reducing computational time and resource requirements. This innovative approach holds great promise for accelerating the discovery of small molecule drugs targeting miRNA-regulated pathways, addressing a critical gap in miRNA therapeutics.

Graphical abstractDownload: Download high-res image (188KB)Download: Download full-size imagePrevious article in issueNext article in issueKeywords

microRNA-protein complex

Deep learning

Drug discovery

Virtual screening

Recommended articles

Peer review under responsibility of Xi'an Jiaotong University.

© 2025 The Authors. Published by Elsevier B.V. on behalf of Xi’an Jiaotong University.